Evoke Wealth’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-29,595
| Closed | -$3.58M | – | 405 |
|
|
2026
Q1 | $3.58M | Buy |
29,595
+859
| +3% | +$99.2K | 0.06% | 109 |
|
|
2025
Q4 | $3.05M | Buy |
28,736
+1,331
| +5% | +$125K | 0.06% | 130 |
|
|
2025
Q3 | $2.32M | Buy |
27,405
+1,609
| +6% | +$133K | 0.05% | 149 |
|
|
2025
Q2 | $2.06M | Buy |
25,796
+8,047
| +45% | +$640K | 0.05% | 146 |
|
|
2025
Q1 | $1.61M | Sell |
17,749
-278
| -2% | -$26K | 0.04% | 153 |
|
|
2024
Q4 | $1.81M | Buy |
18,027
+4,303
| +31% | +$444K | 0.05% | 136 |
|
|
2024
Q3 | $1.57M | Buy |
+13,724
| New | +$1.63M | 0.04% | 146 |
|
|
2024
Q2 | – | Sell |
-13,988
| Closed | -$1.86M | – | 283 |
|
|
2024
Q1 | $1.86M | Buy |
+13,988
| New | +$1.72M | 0.06% | 121 |
|
|
2023
Q4 | – | Sell |
-14,421
| Closed | -$1.5M | – | 252 |
|
|
2023
Q3 | $1.5M | Buy |
14,421
+323
| +2% | +$34.8K | 0.05% | 139 |
|
|
2023
Q2 | $1.64M | Sell |
14,098
-99,768
| -88% | -$11.3M | 0.06% | 124 |
|
|
2023
Q1 | $838K | Sell |
113,866
-3,788
| -3% | -$409K | 0.03% | 172 |
|
|
2022
Q4 | $902K | Buy |
117,654
+110,551
| +1,556% | +$11.3M | 0.03% | 173 |
|
|
2022
Q3 | $531K | Buy |
7,103
+990
| +16% | +$88.4K | 0.02% | 206 |
|
|
2022
Q2 | $562K | Sell |
6,113
-213
| -3% | -$18.9K | 0.02% | 205 |
|
|
2022
Q1 | $523K | Buy |
6,326
+111
| +2% | +$8.75K | 0.02% | 230 |
|
|
2021
Q4 | $404K | Buy |
6,215
+17
| +0.3% | +$1.35K | 0.01% | 260 |
|
|
2021
Q3 | $394K | Hold |
6,198
| – | – | 0.01% | 255 |
|
|
2021
Q2 | $408K | Sell |
6,198
-628
| -9% | -$46.7K | 0.02% | 264 |
|
|
2021
Q1 | $506K | Buy |
6,826
+1,614
| +31% | +$119K | 0.02% | 218 |
|
|
2020
Q4 | $410K | Buy |
5,212
+53
| +1% | +$4.05K | 0.03% | 165 |
|
|
2020
Q3 | $411K | Buy |
5,159
+514
| +11% | +$40.3K | 0.03% | 148 |
|
|
2020
Q2 | $384K | Sell |
4,645
-660
| -12% | -$49.7K | 0.04% | 134 |
|
|
2020
Q1 | $392K | Sell |
5,305
-2,862
| -35% | -$225K | 0.06% | 116 |
|
|
2019
Q4 | $714K | Buy |
8,167
+81
| +1% | +$6.65K | 0.09% | 100 |
|
|
2019
Q3 | $654K | Buy |
+8,086
| New | +$648K | 0.08% | 125 |
|
Other funds holding MRK
Evoke Wealth's MRK Position: Q2 2026 in Review
Evoke Wealth sold out of Merck (MRK) in Q2 2026, closing a stake of 29,595 shares — an estimated $3.58M sold.
Evoke Wealth first reported a position in MRK in Q3 2019 and held it in 25 quarters. The position peaked at $3.58M in Q1 2026. 3,844 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Evoke Wealth reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
- Evoke Wealth sold 29,595 Merck shares in Q2 2026, an estimated $3.58M.
- Evoke Wealth first reported a position in Merck in Q3 2019 and held it in 25 quarters.
- Evoke Wealth's Merck position peaked at $3.58M in Q1 2026.
- 3,844 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Evoke Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.